PRIMED-AI: Translating Models to Clinic (UG3/UH3 Clinical Trial Optional)
ID: 359666Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359666
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a funding opportunity titled "PRIMED-AI: Translating Models to Clinic," aimed at developing innovative AI-based tools that integrate clinical imaging with multimodal health data to enhance personalized medicine for patients with chronic conditions. This initiative, part of the Precision Medicine with Artificial Intelligence program, will utilize a biphasic mechanism focusing initially on rigorous AI model building through the analysis of large datasets, with successful projects advancing to evaluate the clinical utility of AI-driven Clinical Decision Support tools. The estimated total program funding is $10.2 million, with applications expected to be solicited after the synopsis posting on July 1, 2025, and a closing date anticipated on November 1, 2025. Interested applicants can contact Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756 for further information.

    Point(s) of Contact
    Sahana N. Kukke, PhD Office of the Director/NIH Common Fund, DPCPSI, OD
    (301) 402-3756
    ODPRIMED-AI@od.nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    PRIMED-AI: Academic-Industrial Partnerships (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity titled "PRIMED-AI: Academic-Industrial Partnerships (UG3/UH3 Clinical Trial Optional)" aimed at developing innovative AI-based tools that integrate clinical imaging with multimodal health data to enhance personalized medicine for patients with chronic conditions. This initiative will focus on fostering collaborations between academic institutions and industry partners to improve data integration and interoperability, followed by algorithm development and performance testing in a subsequent phase. The estimated total program funding is $2.9 million, with applications expected to open in July 2025 and close in November 2025, while the anticipated award date is September 2026. Interested parties can reach out to Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756 for further information.
    PRIMED-AI: Multi-use Framework Playbooks (UG3 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "PRIMED-AI: Multi-use Framework Playbooks," aimed at supporting the development of AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine. This initiative seeks to fund projects that will create "playbooks" for the responsible use of PRIMED-AI models, focusing on error mitigation, data management, and regulatory preparation. With an estimated total program funding of $650,000, the opportunity is open to small businesses, and while applications are not currently being solicited, interested parties are encouraged to prepare for collaboration and project development ahead of the anticipated synopsis posting on July 1, 2025. For further inquiries, potential applicants can contact Dr. Sahana N. Kukke at ODPRIMED-AI@od.nih.gov or by phone at 301-402-3756.
    PRIMED-AI: Logistics Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "PRIMED-AI: Logistics Center," aimed at developing innovative AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine for patients with chronic health conditions. This initiative will establish a Logistics Center that provides administrative infrastructure through three integrated cores—Administration, Evaluation, and Outreach—to manage consortium activities, including governance, workshops, and community engagement. The estimated total program funding is $2,750,000, with applications not currently being solicited; however, potential applicants are encouraged to prepare for collaboration and project development ahead of the anticipated Notice of Funding Opportunity (NOFO) release on July 1, 2025. For further inquiries, interested parties may contact Dr. Sahana N. Kukke at 301-402-3756 or via email at ODPRIMED-AI@od.nih.gov.
    PRIMED-AI: Validation Center (U54 Clinical Trial Not Allowed) 
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing the upcoming opportunity for the PRIMED-AI: Validation Center program, which aims to develop AI-based tools that integrate clinical imaging with various health data types to enhance personalized medicine for patients with chronic conditions. This initiative will serve as an independent hub for the verification, validation, and uncertainty quantification of AI-enabled Clinical Decision Support (CDS) tools, focusing on the systematic retesting and harmonization of deliverables to characterize their performance comprehensively. The program is particularly relevant for small businesses with expertise in the validation of CDS tools, and while applications are not currently being solicited, interested parties are encouraged to prepare for future submissions. The estimated total program funding is $3,900,000, with key dates including a synopsis post date of July 1, 2025, and an estimated award date of September 1, 2026. For further inquiries, contact Sahana N. Kukke, PhD, at ODPRIMED-AI@od.nih.gov or call 301-402-3756.
    New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies," aimed at advancing research in diabetes control systems. This initiative seeks to overcome barriers to effective open- and closed-loop diabetes management through innovative approaches, including the development of AI/machine learning-driven tools, novel hormone delivery methods, and digital twin modeling to enhance decision support systems. With an estimated total program funding of $3 million, the NIH anticipates awarding approximately six grants, with applications expected to open in September 2025 and close by October 2025. Interested applicants can reach out to Guillermo Arreaza-Rubín at ga96b@nih.gov or call 301-594-4724 for further information.
    Artificial Intelligence and Technology Collaboratory
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to announce a funding opportunity for the Artificial Intelligence and Technology Collaboratory (AITC) Program, aimed at advancing research in aging and Alzheimer's disease through innovative AI and technology solutions. This program seeks applications from small businesses to develop and implement AI approaches while addressing ethical challenges and promoting best practices in aging research. The AITC Program will serve as a national resource, supporting collaborative teams across various disciplines to tackle emerging priorities in the field. Interested applicants should note that applications are not currently being solicited, but they are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of August 15, 2025, and a closing date of October 15, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Krupenevich at NIAAITC@nih.gov.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for clinical studies aimed at advancing next-generation devices for recording and modulation in the human central nervous system, under the BRAIN Initiative. This initiative seeks to support small clinical trials that provide critical data necessary for the development of devices intended to treat central nervous system disorders, particularly those requiring an Investigational Device Exemption (IDE) from the FDA. The funding is crucial for enhancing neurotechnology and improving treatment outcomes, with NIH planning to allocate approximately $10 million annually for 5 to 7 awards, each with a maximum budget of $1.5 million per year for up to five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by September 28, 2026.
    Artificial Intelligence and Technology Collaboratory Coordinating Center
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming opportunity for a Cooperative Agreement to establish the Artificial Intelligence and Technology Collaboratory Coordinating Center (AITCC) under the National Institute on Aging (NIA). This initiative aims to promote the development and implementation of artificial intelligence (AI) and technology approaches to advance research in aging, Alzheimer's disease (AD), and related dementias (ADRD), fostering collaboration among diverse stakeholders in academia, non-profit, and healthcare sectors. The AITCC will serve as a national resource, facilitating research projects and addressing algorithmic fairness in AI applications for individuals experiencing cognitive decline. Interested small businesses are encouraged to prepare for the application process, with the estimated synopsis posting date on August 15, 2025, and a closing date of October 15, 2025. For further inquiries, potential applicants can contact Dr. Rebecca Krupenevich at NIAAITC@nih.gov.
    Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)." This initiative aims to support innovative research projects that integrate advanced imaging techniques, biomarkers, and digital pathomics to enhance the early detection of aggressive cancers and precancerous lesions, thereby improving diagnostic accuracy and reducing overdiagnosis. The program emphasizes the importance of multidisciplinary collaboration in cancer research, particularly focusing on high-risk cancers such as pancreatic and lung cancers. Interested applicants, including higher education institutions, nonprofits, and government entities, must submit their proposals by September 7, 2025, and can find additional information and application details at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)" aimed at supporting innovative research in the development of therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. This cooperative agreement program encourages investigators to conduct translational activities and clinical feasibility studies, with a focus on advancing medical device technology through collaboration with NIH resources for design, testing, and regulatory support. The initiative is particularly significant as it seeks to accelerate the clinical introduction of medical technologies, ultimately improving patient outcomes while adhering to best practices in research and development. Interested applicants, including various eligible institutions and organizations, must submit their proposals by January 28, 2028, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.